Skip to main content

Table 2 Outcomes of 7 dogs that underwent sclerotherapy

From: Perioperative characteristics, histologic diagnosis, complications, and outcomes of dogs undergoing percutaneous drainage, sclerotherapy or surgical management of intrarenal cystic lesions: 18 dogs (2004–2021)

Dog number

Histologic diagnosis

Previous treatment

Clinical signs related to ICL at FUa

Resolution of preprocedural clinical signs at last FUa

Progression in size of treated ICL(s) at last FU imaginga

Azotemia pre-procedure

Azotemia on FU biochemistrya

Additional treatment performed

Dead, alive, LTFU post treatment

3

NP

NP

No

(571 days)

Yes

Cyst right kidney: 46.1% its original size; cyst left kidney resolved

(22 days)

No

No

(549 days)

No

Alive

(571 days post index treatment)

5

Cystadenocarcinoma

NP

No

(97 days)

Yes

100% its original size

(97 days)

No

NP

PCD (289 days); Laparoscopic deroofing (530 days)

Died, unknown cause

(732 days post index treatment)

7

Renal cyst

NP

No

(44 days)

N/A

3 cysts treated: 78% its original size; 146.7% its original size; resolved

(44 days)

No

No

(13 days)

No

LTFU

(44 days post index treatment)

8

NP

NP

No

(278 days)

Yes

Resolved

(258 days)

Yes

No

(266 days)

No

Euthanized, vestibular disease

(date unknown)

9

NP

NP

No

(42 days)

N/A

41.7% its original size

(42 days)

No

NP

No

LTFU

(42 days post index treatment)

10

Renal adenoma

PCD performed twice (57 days and 18 days)

Not available

Not available

125% its original size

(13 days)

No

NP

Laparoscopic deroofing and omentalization

(24 days)

Alive

(349 days; 406 days post index treatment)

13

NP

NP

No

(914 days)

Yes

2 cysts treated: 22.2% & 125% its original size (117 days)

Yes

Yes but improved

(117 days)

No

Alive

(914 days post index treatment)

  1. Days presented in parenthesis are calculated from the date of the sclerotherapy
  2. FU follow-up, LTFU lost to follow-up, N/A not applicable, NP not performed
  3. a Denotes date of last follow-up either after sclerotherapy or until the date of revision treatment